The Times They Are A-Changin': A Perspective on Alliance Transplant and Cell Based Therapies

In 1965, E. Donnall Thomas described some of the challenges facing the nascent field of allogeneic hematopoietic cell transplantation (HCT). Pre-clinical and clinical observations at the time led to an emerging understanding that the use of immunosuppressive drugs and donor selection based on histocompatibility matching could reduce the incidence of marrow graft rejection and of secondary disease, now known as graft-versus-host disease (GVHD). More than five decades later, significant progres


UPCOMING MEETINGS

2020 Group Meetings | May 14-16 + November 5-7
2021 Group Meetings | May 13-15 + November 4-6

Loews Chicago O'Hare Hotel, Rosemont, IL 60018
open to all Alliance members

TWEETS

FROM THE NCI